Adaptive Biotechnologies Corp
ADPT
58 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 12 11:33 PM | Susan BobulskyChief Commercial Officer, MRD | Sale | 3,000 | $25.00 | $75.0K | 396,989(D) | View → |
| Aug 10, 2026 | Aug 10 8:37 PM | SUSAN BOBULSKY | Proposed Sale | 3,000 | $24.93 | $74.8K | — | View → |
| Jul 30, 2026 | Aug 3 10:26 PM | Susan BobulskyChief Commercial Officer, MRD | Sale | 1,299 | $24.00 | $31.2K | 399,989(D) | View → |
| Jul 30, 2026 | Jul 30 8:38 PM | SUSAN BOBULSKY | Proposed Sale | 1,299 | $22.56 | $29.3K | — | View → |
| Jul 21, 2026 | Jul 23 11:34 PM | Harlan S RobinsChief Scientific Officer | Sale | 492,400 | $21.89 | $10.8M | 812,058(D) | View → |
| Jul 21, 2026 | Jul 21 9:20 PM | Harlan Robins | Proposed Sale | 492,400 | $22.58 | $11.1M | — | View → |
| Jul 16, 2026 | Jul 20 11:19 PM | Susan BobulskyChief Commercial Officer, MRD | Sale | 5,000 | $23.00 | $115.0K | 401,288(D) | View → |
| Jul 15, 2026 | Jul 17 11:23 PM | Francis LOChief People Officer | Sale | 105,762 | $22.59 | $2.4M | 230,713(D) | View → |
| Jul 16, 2026 | Jul 16 8:34 PM | SUSAN BOBULSKY | Proposed Sale | 5,000 | $22.90 | $114.5K | — | View → |
| Jul 2, 2026 | Jul 7 10:52 PM | Harlan S RobinsChief Scientific Officer | Sale | 386,240 | $22.01 | $8.5M | 1,019,658(D) | View → |
| Jul 2, 2026 | Jul 6 11:19 PM | Francis LOChief People Officer | Sale | 44,838 | $22.59 | $1.0M | 230,713(D) | View → |
| Jul 1, 2026 | Jul 6 11:19 PM | Francis LOChief People Officer | Sale | 51,004 | $22.45 | $1.1M | 237,688(D) | View → |
| Jul 1, 2026 | Jul 6 11:15 PM | Susan BobulskyChief Commercial Officer, MRD | Sale | 487 | $22.00 | $10.7K | 406,288(D) | View → |
| Jul 2, 2026 | Jul 2 9:43 PM | Harlan Robins | Proposed Sale | 386,240 | $21.19 | $8.2M | — | View → |
| Jul 1, 2026 | Jul 1 8:35 PM | FRANCIS LO | Proposed Sale | 199,260 | $21.45 | $4.3M | — | View → |
| Jul 1, 2026 | Jul 1 8:16 PM | SUSAN BOBULSKY | Proposed Sale | 487 | $21.45 | $10.4K | — | View → |
| Jun 29, 2026 | Jun 30 11:25 PM | Sharon BenzenoChief Commercial Ofc Imm Med | Sale | 154,768 | $21.14 | $3.3M | 221,278(D) | View → |
| Jun 26, 2026 | Jun 30 11:25 PM | Sharon BenzenoChief Commercial Ofc Imm Med | Sale | 11,034 | $21.00 | $231.7K | 272,751(D) | View → |
| Jun 25, 2026 | Jun 29 11:52 PM | Susan BobulskyChief Commercial Officer, MRD | Sale | 5,000 | $20.50 | $102.5K | 406,775(D) | View → |
| Jun 25, 2026 | Jun 29 11:49 PM | Michelle Renee GriffinDirector | Sale | 52,084 | $20.18 | $1.1M | 15,625(D) | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 14 1:36 AM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $6.55 | 77,549(D) | View → |
| Mar 11, 2026 | Mar 14 1:36 AM | Julie RubinsteinPresident and COO | Option Exercise | 14,722 | $6.55 | 92,271(D) | View → |
| Mar 10, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 15,122 | $12.14 | 403,539(D) | View → |
| Mar 9, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 403,939(D) | View → |
| Mar 6, 2026 | Mar 11 12:04 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 415,820(D) | View → |
| Mar 3, 2026 | Mar 6 1:05 AM | Michelle Renee GriffinDirector | Option Exercise | 48,044 | $3.99 | 0(D) | View → |
| Mar 5, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 427,701(D) | View → |
| Mar 4, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 439,582(D) | View → |
| Mar 3, 2026 | Mar 6 12:42 AM | Julie RubinsteinPresident and COO | Option Exercise | 26,603 | $12.14 | 451,463(D) | View → |
| Feb 4, 2026 | Feb 7 12:30 AM | Kyle PiskelChief Financial Officer | Option Exercise | 2,145 | $12.14 | 2,146(D) | View → |
← Previous
Page 3 of 3